M&A Deal Summary

Axys Pharmaceuticals Acquires Sequana Therapeutics

On November 4, 1997, Axys Pharmaceuticals acquired life science company Sequana Therapeutics for 166M USD

Acquisition Highlights
  • This is Axys Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Axys Pharmaceuticals’ largest (disclosed) transaction.
  • This is Axys Pharmaceuticals’ 1st transaction in the United States.
  • This is Axys Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary
Date 1997-11-04
Target Sequana Therapeutics
Sector Life Science
Buyer(s) Axys Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 166M USD

Target

Sequana Therapeutics

La Jolla, California, United States
Sequana Therapeutics is a biotechnology company focused on development of gene discovery technology & functional genomics to discover & characterise genes that caused certain common diseases.

Search 202,196 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Axys Pharmaceuticals

South San Francisco, California, United States
Category Company
Founded 1989
Sector Life Science
Employees168
DESCRIPTION

Axys Pharmaceuticals, Inc. is a drug research and development firm.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (1997) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal